Hib-DTaP vaccine - Baxter International
Alternative Names: Hib-DTP-acellular vaccine - North American VaccineLatest Information Update: 12 Oct 2006
Price :
$50 *
At a glance
- Originator Baxter International
- Class Haemophilus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diphtheria; Haemophilus infections; Pertussis; Tetanus
Most Recent Events
- 27 Jun 2000 North American Vaccine has been acquired by and merged into Baxter International
- 26 May 1999 Phase-I clinical trials for Diphtheria in USA (IM)
- 26 May 1999 Phase-I clinical trials for Haemophilus infections in USA (IM)